vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and ONESPAWORLD HOLDINGS Ltd (OSW). Click either name above to swap in a different company.
ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $151.7M, roughly 1.6× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 5.0%, a 2.8% gap on every dollar of revenue. On growth, ONESPAWORLD HOLDINGS Ltd posted the faster year-over-year revenue change (11.5% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $14.9M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 7.1%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
NUTX vs OSW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $242.1M |
| Net Profit | $11.8M | $12.1M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | 6.8% |
| Net Margin | 7.8% | 5.0% |
| Revenue YoY | -41.1% | 11.5% |
| Net Profit YoY | -80.8% | -16.2% |
| EPS (diluted) | $2.34 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $242.1M | ||
| Q3 25 | $267.8M | $258.5M | ||
| Q2 25 | $244.0M | $240.7M | ||
| Q1 25 | $211.8M | $219.6M | ||
| Q4 24 | $257.6M | $217.2M | ||
| Q3 24 | $78.8M | $241.7M | ||
| Q2 24 | $76.1M | $224.9M | ||
| Q1 24 | $67.5M | $211.2M |
| Q4 25 | $11.8M | $12.1M | ||
| Q3 25 | $55.4M | $24.3M | ||
| Q2 25 | $-17.7M | $19.9M | ||
| Q1 25 | $21.2M | $15.3M | ||
| Q4 24 | $61.6M | $14.4M | ||
| Q3 24 | $-8.8M | $21.6M | ||
| Q2 24 | $-364.0K | $15.8M | ||
| Q1 24 | $-364.0K | $21.2M |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | 6.8% | ||
| Q3 25 | 48.7% | 10.2% | ||
| Q2 25 | 13.8% | 9.2% | ||
| Q1 25 | 38.1% | 7.7% | ||
| Q4 24 | 44.4% | 7.9% | ||
| Q3 24 | 12.3% | 10.3% | ||
| Q2 24 | 7.0% | 8.4% | ||
| Q1 24 | 2.1% | 8.0% |
| Q4 25 | 7.8% | 5.0% | ||
| Q3 25 | 20.7% | 9.4% | ||
| Q2 25 | -7.3% | 8.3% | ||
| Q1 25 | 10.0% | 7.0% | ||
| Q4 24 | 23.9% | 6.6% | ||
| Q3 24 | -11.2% | 8.9% | ||
| Q2 24 | -0.5% | 7.0% | ||
| Q1 24 | -0.5% | 10.0% |
| Q4 25 | $2.34 | $0.12 | ||
| Q3 25 | $7.76 | $0.23 | ||
| Q2 25 | $-2.95 | $0.19 | ||
| Q1 25 | $3.33 | $0.15 | ||
| Q4 24 | $11.56 | $0.13 | ||
| Q3 24 | $-1.72 | $0.20 | ||
| Q2 24 | $-0.07 | $0.15 | ||
| Q1 24 | $-0.08 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $16.3M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $329.4M | $542.6M |
| Total Assets | $918.5M | $707.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $16.3M | ||
| Q3 25 | $166.0M | $29.6M | ||
| Q2 25 | $96.7M | $35.0M | ||
| Q1 25 | $84.7M | $22.6M | ||
| Q4 24 | $40.6M | $57.4M | ||
| Q3 24 | $46.9M | $48.8M | ||
| Q2 24 | $40.8M | $62.5M | ||
| Q1 24 | $30.0M | $65.4M |
| Q4 25 | — | $84.0M | ||
| Q3 25 | — | $85.2M | ||
| Q2 25 | — | $96.2M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.7M | ||
| Q2 24 | — | $123.8M | ||
| Q1 24 | — | $138.6M |
| Q4 25 | $329.4M | $542.6M | ||
| Q3 25 | $317.2M | $552.8M | ||
| Q2 25 | $235.3M | $548.3M | ||
| Q1 25 | $176.9M | $530.6M | ||
| Q4 24 | $132.4M | $554.5M | ||
| Q3 24 | $60.4M | $540.1M | ||
| Q2 24 | $62.7M | $532.7M | ||
| Q1 24 | $63.0M | $515.5M |
| Q4 25 | $918.5M | $707.1M | ||
| Q3 25 | $964.5M | $732.6M | ||
| Q2 25 | $841.0M | $731.8M | ||
| Q1 25 | $761.9M | $708.7M | ||
| Q4 24 | $655.3M | $746.4M | ||
| Q3 24 | $438.5M | $734.0M | ||
| Q2 24 | $422.4M | $756.8M | ||
| Q1 24 | $404.3M | $763.6M |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.18× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $20.0M |
| Free Cash FlowOCF − Capex | $69.0M | $14.9M |
| FCF MarginFCF / Revenue | 45.5% | 6.2% |
| Capex IntensityCapex / Revenue | 0.9% | 2.1% |
| Cash ConversionOCF / Net Profit | 5.95× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $68.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $20.0M | ||
| Q3 25 | $99.5M | $33.2M | ||
| Q2 25 | $27.3M | $20.3M | ||
| Q1 25 | $51.0M | $10.1M | ||
| Q4 24 | $54.0K | $16.6M | ||
| Q3 24 | $6.8M | $28.6M | ||
| Q2 24 | $13.3M | $18.7M | ||
| Q1 24 | $3.1M | $15.0M |
| Q4 25 | $69.0M | $14.9M | ||
| Q3 25 | $99.2M | $27.6M | ||
| Q2 25 | $26.5M | $17.6M | ||
| Q1 25 | $50.9M | $8.4M | ||
| Q4 24 | $-341.0K | $13.2M | ||
| Q3 24 | $6.2M | $27.5M | ||
| Q2 24 | $12.7M | $17.6M | ||
| Q1 24 | $2.3M | $13.7M |
| Q4 25 | 45.5% | 6.2% | ||
| Q3 25 | 37.0% | 10.7% | ||
| Q2 25 | 10.9% | 7.3% | ||
| Q1 25 | 24.0% | 3.8% | ||
| Q4 24 | -0.1% | 6.1% | ||
| Q3 24 | 7.8% | 11.4% | ||
| Q2 24 | 16.7% | 7.8% | ||
| Q1 24 | 3.4% | 6.5% |
| Q4 25 | 0.9% | 2.1% | ||
| Q3 25 | 0.1% | 2.2% | ||
| Q2 25 | 0.3% | 1.1% | ||
| Q1 25 | 0.0% | 0.8% | ||
| Q4 24 | 0.2% | 1.5% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 0.7% | 0.5% | ||
| Q1 24 | 1.1% | 0.6% |
| Q4 25 | 5.95× | 1.65× | ||
| Q3 25 | 1.80× | 1.36× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | 2.40× | 0.66× | ||
| Q4 24 | 0.00× | 1.15× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | 0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
